文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肺腺鳞癌肺叶切除术后送检淋巴结及淋巴结比值对病理淋巴结分类的影响

The Effect of Examined Lymph Nodes and Lymph Node Ratio on Pathological Nodal Classification in the Lung Adenosquamous Carcinoma After Lobectomy.

作者信息

Feng Shoujie, Liu Xiangming, Huang Bing, Shi Jing, Zhang Hao

机构信息

Department of Thoracic Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.

Thoracic Surgery Laboratory, Xuzhou Medical University, 84 West Huaihai Road, Xuzhou, China.

出版信息

Front Surg. 2022 Jun 9;9:909810. doi: 10.3389/fsurg.2022.909810. eCollection 2022.


DOI:10.3389/fsurg.2022.909810
PMID:35756483
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9218197/
Abstract

OBJECTIVE: The effects of examined lymph nodes (LNs) and lymph node ratio (LNR) on pN classification and the prognosis are unclear in lung adenosquamous carcinoma (ASC) patients. Thus, this study aimed to investigate the significance of LNs and LNR in the prognosis of ASC and the impact of the abovementioned factors on the pN classification. METHODS: Patients diagnosed with pathological stage T1-4N0-2M0 ASC from the Surveillance Epidemiology and End Results database were included in the study. The primary clinical endpoint was cancer-specific survival (CSS). The optimal cutoff values of the LNs and LNR were determined. An LN indicator, including pN0 #LNs ≤9, pN0 #LNs >9, pN #LNR ≤0.53, and pN #LNR > 0.53, was developed. Concordance index (C-index) was used to compare the prognostic predictive ability between N classification and LN indicator. The univariable and multivariable Cox regression analyses were used in this study. RESULTS: The cohort of 1,416 patients were included in the study. The level of LNs stratified the patients without metastasis of lymph nodes (pN0 #LNs ≤9 vs. pN0 #LNs >9, unadjusted hazard ratio [HR] = 1.255,  = 0.037). Two groups based on the cutoff value of LNR differentiated prognosis of patients with metastasis of lymph nodes (pN #LNR >0.53 vs. pN #LNR ≤0.53, unadjusted HR = 1.703,  = 0.001). The LN indicator had a much better predictive ability over N classification in this cohort (LN indicator: C-index = 0.615; N classification: C-index = 0.602,  = 0.001). CONCLUSIONS: We explored clinicopathological factors affecting prognosis in resected lung ASC patients. Besides, the LN indicator was confirmed to be played an essential role in affecting the survival rate in ASC patients. The high-level LNs or low-level LNR might be corelated to improved survival outcomes.

摘要

目的:在肺腺鳞癌(ASC)患者中,送检淋巴结(LNs)及淋巴结比率(LNR)对pN分期及预后的影响尚不清楚。因此,本研究旨在探讨LNs和LNR在ASC预后中的意义以及上述因素对pN分期的影响。 方法:本研究纳入了监测、流行病学和最终结果数据库中诊断为病理分期T1 - 4N0 - 2M0 ASC的患者。主要临床终点为癌症特异性生存(CSS)。确定了LNs和LNR的最佳截断值。制定了一个LN指标,包括pN0 #LNs≤9、pN0 #LNs>9、pN #LNR≤0.53和pN #LNR>0.53。一致性指数(C-index)用于比较N分期与LN指标之间的预后预测能力。本研究采用单变量和多变量Cox回归分析。 结果:本研究共纳入1416例患者。LNs水平对无淋巴结转移患者进行了分层(pN0 #LNs≤9与pN0 #LNs>9,未调整风险比[HR]=1.255,P = 0.037)。基于LNR截断值的两组区分了有淋巴结转移患者的预后(pN #LNR>0.53与pN #LNR≤0.53,未调整HR = 1.703,P = 0.001)。在该队列中,LN指标比N分期具有更好的预测能力(LN指标:C-index = 0.615;N分期:C-index = 0.602,P = 0.001)。 结论:我们探讨了影响肺ASC切除患者预后的临床病理因素。此外,证实LN指标在影响ASC患者生存率方面起着重要作用。高水平的LNs或低水平的LNR可能与改善生存结果相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e770/9218197/790ed96af1ce/fsurg-09-909810-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e770/9218197/c303e906f12e/fsurg-09-909810-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e770/9218197/de8df8b7abd5/fsurg-09-909810-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e770/9218197/0ddb137e504b/fsurg-09-909810-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e770/9218197/31d5583c091d/fsurg-09-909810-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e770/9218197/790ed96af1ce/fsurg-09-909810-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e770/9218197/c303e906f12e/fsurg-09-909810-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e770/9218197/de8df8b7abd5/fsurg-09-909810-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e770/9218197/0ddb137e504b/fsurg-09-909810-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e770/9218197/31d5583c091d/fsurg-09-909810-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e770/9218197/790ed96af1ce/fsurg-09-909810-g005.jpg

相似文献

[1]
The Effect of Examined Lymph Nodes and Lymph Node Ratio on Pathological Nodal Classification in the Lung Adenosquamous Carcinoma After Lobectomy.

Front Surg. 2022-6-9

[2]
Reconsidering N component of cancer staging for T1-2N0-2M0 small-cell lung cancer: a retrospective study based on multicenter cohort.

Respir Res. 2023-6-23

[3]
Revolutionizing T3-4N0-2M0 gastric cancer staging with an innovative pathologic N classification system.

J Gastrointest Surg. 2024-8

[4]
A Proposal for Combination of Lymph Node Ratio and Anatomic Location of Involved Lymph Nodes for Nodal Classification in Non-Small Cell Lung Cancer.

J Thorac Oncol. 2016-5-17

[5]
Positive lymph node ratio predicts adverse prognosis for patients with lymph nodes metastatic hypopharyngeal squamous cell carcinoma after primary surgery.

Transl Cancer Res. 2022-3

[6]
Evaluation of the prognostic value of the metastatic lymph node ratio for gastric cancer.

Am J Surg. 2013-10-12

[7]
Log odds of positive lymph nodes may predict survival benefit in patients with node-positive non-small cell lung cancer.

Lung Cancer. 2018-5-23

[8]
Is Lymph Node Ratio a Prognostic Factor for Patients With Oral Squamous Cell Carcinoma?

J Oral Maxillofac Surg. 2019-7

[9]
The assessment of the optimal number of examined lymph nodes and prognostic models based on lymph nodes for predicting survival outcome in patients with stage N3b gastric cancer.

Asia Pac J Clin Oncol. 2021-4

[10]
Can lymph node ratio replace pn categories in the tumor-node-metastasis classification system for esophageal cancer?

J Thorac Oncol. 2014-8

引用本文的文献

[1]
Role of Postoperative Radiotherapy on High-Risk Stage pIIIA-N2 Non-Small Cell Lung Cancer Patients After Complete Resection and Adjuvant Chemotherapy: A Retrospective Cohort Study.

World J Oncol. 2024-4

本文引用的文献

[1]
Comprehensive analysis of the autophagy-dependent ferroptosis-related gene FANCD2 in lung adenocarcinoma.

BMC Cancer. 2022-3-2

[2]
Surgery and Surgery Approach Affect Survival of Patients With Stage I-IIA Small-Cell Lung Cancer: A Study Based SEER Database by Propensity Score Matching Analysis.

Front Surg. 2022-2-11

[3]
A Novel Inflammatory-Related Gene Signature Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma.

Front Genet. 2022-1-5

[4]
On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial.

Mol Cancer. 2022-1-3

[5]
Incidence and survival analyses for occult lung cancer between 2004 and 2015: a population-based study.

BMC Cancer. 2021-9-9

[6]
Improving the accuracy of prognosis for clinical stage I solid lung adenocarcinoma by radiomics models covering tumor per se and peritumoral changes on CT.

Eur Radiol. 2022-2

[7]
A Nomogram to Predict Long-Term Survival Outcomes of Patients Who Undergo Pneumonectomy for Non-small Cell Lung Cancer With Stage I-IIIB.

Front Surg. 2021-4-29

[8]
Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic disease.

Lung Cancer. 2021-5

[9]
Cancer Statistics, 2021.

CA Cancer J Clin. 2021-1

[10]
Association between number of dissected lymph nodes and survival in stage IA non-small cell lung cancer: a propensity score matching analysis.

World J Surg Oncol. 2020-12-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索